The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
Welcome to the all-new HOPA Resources where we consider all searches “advanced searches.”
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.Join or renew your membership today!
The HOPA Board of Directors opened their Mid-Summer meeting by welcoming back Heidi Finnes unto the Board, to carry out the final term year of Edward Li.Read more
November Journal Club – Attend November's Journal Club on November 13th from 2:00–3:00 pm CT.
Latest Issue of HOPA News now available ‒ read about pharmacy and association events, clinical content, and practice management information.
Three downloadable flyers you can give to patients to help them understand oncology pharmacy are now available.
Member Spotlight – news about our members' accomplishments, awards, research endeavors, and speaking engagements.
Glasdegib (DAURISMO, Pfizer Labs) in combination with low-dose cytarabine (LDAC), for newly-diagnosed acute myeloid leukemia (AML) in...
Emapalumab (GAMIFANT, Novimmune SA), a monoclonal antibody that binds and neutralizes interferon gamma, for adult and pediatric...
Talazoparib (TALZENNA, Pfizer Inc.) a poly (ADP-ribose) polymerase (PARP) inhibitor, for patients with deleterious or suspected...
Lorlatinib (LORBRENA, Pfizer, Inc.) or patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer...
Save the date for HOPA Ahead 2019 - April 3–6, 2019 - Fort Worth, TX.
The 6th Annual Practice Management Course takes place September 14–15, 2018.
BCOP Programming: Specialty Sessions & Updates Course
Now pharmacists can fulfill all of their BCOP recertification education with HOPA— the experts in clinical oncology pharmacy. HOPA recently was awarded status as a BCOP recertification credit provider by the Board of Pharmacy Specialties (BPS), and will now provide 38 credits of education per year in a variety of delivery options.
The HOPA BCOP recertification courses address the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.Learn More
HOPA has created several patient education videos for you to share with your patients and their families.